Trials / Completed
CompletedNCT06819046
Improved Efficacy of Selective Laser Trabeculoplasty With the Addition of Rocklatan Post-treatment vs Artificial Tears Post-treatment
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Colorado Ophthalmology Associates PC · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
A randomized, single-site, parallel-group, prospective study of patients who are candidates for SLT, to study the effect of IOP change with Rocklatan vs artificial tears.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rocklatan | netarsudil and latanoprost ophthalmic solution 0.02%/0.005% |
| DRUG | Systane Ultra | artificial tears |
Timeline
- Start date
- 2025-02-14
- Primary completion
- 2025-12-17
- Completion
- 2025-12-17
- First posted
- 2025-02-11
- Last updated
- 2026-03-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06819046. Inclusion in this directory is not an endorsement.